Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02367365 · ClinicalTrials.gov registry record
Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 75
- Enrollment target
NCT02367365 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 75 participants.
The verdict
NCT02367365 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
Neovascular Age-Related Macular Degeneration (NV AMD) remains the leading cause of vision loss among people over 65. Intravitreal injections with drugs that block VEGF have revolutionized treatment of NV AMD. However, less than 40% of treated patients have clinically significant imporovement in vision. In this study, we will determine the relative frequency of neovascular subtypes in two groups: 1) a representative, treatment-naive NV AMD patient population, and 2) a population of patients who develop recurrent NV AMD activity while off treatment and assess the frequency of persistent disease activity (PDA) according to specific neovascular morphologic subtypes. This information will clarify the scope of the PDA problem and will identify patients with PDA who may benefit from additional therpeutic strategies.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2014-12 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02367365
The ClinicalTrials.gov registry entry for NCT02367365 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT02367365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02367365 about?
NCT02367365 is a clinical study titled "Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD". Neovascular Age-Related Macular Degeneration (NV AMD) remains the leading cause of vision loss among people over 65. Intravitreal injections with drugs that block VEGF have revolutionized treatment of NV AMD. However, less than 40% of treated patients have clinically significant imporovement in visi...
What is the current status of trial NCT02367365?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2014-12. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02367365?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT02367365?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.